Clinical Trial Update: External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) [NA]

View source ↗

Summary

Abbott Medical Devices is conducting a clinical trial (XANADO) to evaluate external sensing and neuromodulation for diabetic pain outcomes; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Pain

Snippet

Sponsor: Abbott Medical Devices | Conditions: Chronic Pain | NA | Status: RECRUITING